Company performance
Add to research
Current Price
as of Feb 07, 2025$5.85
P/E Ratio
N/A
Market Cap
$19.56M
Description
Add to research
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQIrvine, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerRPHM
- Price$5.85+2.81%
Trading Information
- Market cap$19.56M
- Float73.46%
- Average Daily Volume (1m)118,579
- Average Daily Volume (3m)116,675
- EPS-$12.28
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$3.69M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$4.66M
- EV-$19.18M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.26
- Debt/Equity0.90
Documents
Add to research
SEC Filings
Factset Street Account